Drug – bio-affecting and body treating compositions – Designated organic active ingredient containing – Heterocyclic carbon compounds containing a hetero ring...
Reexamination Certificate
2007-05-16
2008-01-29
Habte, Kahsay (Department: 1624)
Drug, bio-affecting and body treating compositions
Designated organic active ingredient containing
Heterocyclic carbon compounds containing a hetero ring...
C514S232800
Reexamination Certificate
active
07323467
ABSTRACT:
The invention discloses and claims therapeutic uses of compounds of general formula (I)Wherein X, R1, R2and R3are as described herein. The invention further discloses processes for preparing them, and novel intermediates therefor.
REFERENCES:
patent: 6075021 (2000-06-01), Evanno et al.
patent: 6262045 (2001-07-01), Evanno et al.
patent: 6395729 (2002-05-01), Ferzaz et al.
patent: 7109194 (2006-09-01), Burnier et al.
patent: WO 98/15552 (1998-04-01), None
patent: WO 99/06406 (1999-02-01), None
patent: WO 00/44384 (2000-08-01), None
Lacapere, J.J., et., al., Peripheral-Type Benzodiazepine Receptor: Structure and Function of a Cholesterol-Binding in Steroid and Bile Acid Biosynthesis, Steroids vol. 68, (2003) pp. 569-585.
Froissant Jacques
Marabout Benoit
Marguet Frank
Puech Frederic
Gupta Balaram
Habte Kahsay
Sanofi-Aventis
LandOfFree
3-heteroaryl-3,5-dihydro-4-oxo-4 H... does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with 3-heteroaryl-3,5-dihydro-4-oxo-4 H..., we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and 3-heteroaryl-3,5-dihydro-4-oxo-4 H... will most certainly appreciate the feedback.
Profile ID: LFUS-PAI-O-3962410